Abstract
EFFECT OF FERMENTED PAPAYA PREPARATION ON DOXORUBICIN INDUCED HEPATOTOXICITY AND NEPHROTOXICITY

Bhavya N. Barot, Jaymesh M. Thadani, Ansarullah, Sunita P. Salunke*

ABSTRACT

Doxorubicin (DOX) is an anthracycline derivative used as an anticancer agent. However, its clinical use is limited due to its severe toxic manifestations. In the present study, we aim to evaluate the protective role of Fermented papaya preparation (FPP) in combating doxorubicin induced oxidative stress. Wistar rats were pretreated with FPP (100 mg/kg bw or 250 mg/kg bw) or saline daily for 28 consecutive days followed by doxorubicin (10 mg/kg bw) induction for next 2 days. Results indicated that pretreatment with FPP significantly decreased serum levels of hepatic markers Serum Glutamate-Pyruvate Transaminase (SGPT) and Serum Glutamate Oxalicacetic Transaminases (SGOT) along with renal marker Creatinine. Further, FPP supplementation significantly increased Superoxide Dismutase (SOD), Glutathione Peroxidase (GPx) and Reduced Glutathione (GSH) (p<0.05) while decreased Malondialdehyes and Calatase levels in kidney and liver. Histological observations demonstrated that FPP pretreatment attenuated DOX induced thickening of the glomerular basement membrane and destructive changes in the renal tubule as well as loss of tissue structural pattern and vacuolization in liver. Thus our results suggest that FPP exhibits significant preclinical potential in combating DOX induced oxidative stress.

Keywords: Doxorubicin, Fermented papaya preparation, Organ toxicity, Oxidative stress Liver, Kidney.


[Full Text Article]   [Download Certificate]

Indexing

Best Article Awards

European Journal of Biomedical and Pharmaceutical Sciences (EJBPS) is giving Best Article Award in every Issue for Best Article and Issue Certificate of Appreciation to the Authors to promote research activity of scholar.

Best Article of current issue :

Dr. Dhrubo Jyoti Sen

Download Article : Click here

News & Updation

  • EJBPS: AUGUST ISSUE PUBLISHED

    AUGUST 2026 Issue has been successfully launched on 1 AUGUST 2026.

  • EJBPS: New Impact Factor 2026

    EJBPS Impact Factor has been Increased from  7.482 to 8.181 for Year 2026.

  • Index Copernicus Value

    EJBPS Received Index Copernicus Value 77.3, due to High Quality Publication in EJBPS at International Level

  • Journal web site support Internet Explorer, Google Chrome, Mozilla Firefox, Opera, Saffari for easy download of article without any trouble.

    .

  • Article Invited for Publication

    Dear Researcher, Article Invited for Publication  in EJBPS coming Issue.

     

Google Scholar Index Copernicus Indian Science Publications Urlich's Periodicals Directory, Proquest, UK (In Process) Research Bible, Fuchu, Tokyo. JAPAN UDLedge Science Citation Index International Society for Research activity (ISRA) Scientific Indexing Services (SIS) InfoBase Index (In Process) SJIF Impact Factor Scholar Article Impact Factor, SAIF Universal Impact Factor CAS (A Division of American Chemical Society) USA (Under Process) Directory of Open Access Journal (DOAJ, Sweden, in process) CiteFactor Directory Of Research Journal Indexing (DRJI) Indian citation Index (ICI) Journal Index (JI, Under Process) Directory of abstract indexing for Journals (DAIJ) Open Access Journals (Under Process) Impact Factor Services For International Journals (IFSIJ) Cosmos Impact Factor Jour Informatics (Under Process) Eurasian Scientific Journal Index (ESJI) International Innovative Journal Impact Factor (IIJIF) Science Library Index, Dubai, United Arab Emirates Global Impact Factor (GIF) (0.377) IP Indexing (IP Value 3.77) Web of Science Group (Under Process) Directory of Research Journals Indexing Scope Database Academia Academia Doi-Digital Online Identifier Doi-Digital Online Identifier ISSN National Centre Zenodo Indexing International CODEN Service, USA

UG/PG/Ph.D Research Publication

Research Scholar of UG/PG/Ph.D can Submit their Research Article/Review Article/Case Study/Short Communication for Publication in EJBPS

Downloads

Copyright From

Covering Letter

                        Author Instruction 
 

PLAGERLUM REPORT